BIOVANTAGE.DK ApS: Financial statements 2019
CVR: 36498544
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
BIOVANTAGE.DK ApS (CVR 36498544) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,663,806 and a net result of DKK -1,863,505 compared with DKK -1,500,987 the year before. That is a decrease of 10.9% compared with the year before. Equity in the 2019 report amounted to DKK -5,865,245. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,663,806
- Profit/Loss
- DKK -1,863,505
- Equity
- DKK -5,865,245
- Total Assets
- DKK 11,482,548
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.7 mio. | -1.9 mio. | -5.9 mio. | 1 |
| 2018 | - | 3 mio. | -1.5 mio. | -4 mio. | 2 |
| 2017 | - | 2.7 mio. | -2 mio. | -2.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOVANTAGE.DK ApS
BIOVANTAGE.DK ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 30 December 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2023, the company reported a gross profit of DKK -243,628 and a net result of DKK -612,916 compared with DKK -264,925 the year before. Equity in the 2023 report amounted to DKK -5,792,487.